NSIM
VKTX icon

North Star Investment Management’s Viking Therapeutics VKTX Stock Holding History

North Star Investment Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Hold
3,058
– – 0.01% 577
2026
Q1 		$99.5K Buy
3,058
+1,485
+94% +$47.7K 0.01% 604
2025
Q4 		$55.3K Sell
1,573
-1,442
-48% -$51.1K ﹤0.01% 652
2025
Q3 		$79.2K Sell
3,015
-500
-14% -$14.9K 0.01% 571
2025
Q2 		$93.1K Sell
3,515
-800
-19% -$21.1K 0.01% 532
2025
Q1 		$104K Sell
4,315
-300
-7% -$9.48K 0.01% 504
2024
Q4 		$186K Buy
4,615
+200
+5% +$11.4K 0.01% 425
2024
Q3 		$280K Buy
4,415
+2,090
+90% +$123K 0.02% 371
2024
Q2 		$123K Buy
2,325
+525
+29% +$34.4K 0.01% 467
2024
Q1 		$148K Buy
+1,800
New +$80.1K 0.01% 462

Other funds holding VKTX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
LA
LBP AM Paris, France $10B AUM 43.88% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

North Star Investment Management's VKTX Position: Q2 2026 in Review

North Star Investment Management held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 3,058 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #577.

North Star Investment Management first reported a position in VKTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $280K in Q3 2024. 116 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • North Star Investment Management held 3,058 shares of Viking Therapeutics worth $119K as of Q2 2026.
  • North Star Investment Management left its Viking Therapeutics share count unchanged in Q2 2026.
  • Viking Therapeutics made up 0.01% of North Star Investment Management's portfolio in Q2 2026, its #577 holding.
  • North Star Investment Management first reported a position in Viking Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • North Star Investment Management's Viking Therapeutics position peaked at $280K in Q3 2024.
  • 116 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.